Metabolic status is another influential variable
Some patients experience therapeutic benefits without significant gastrointestinal symptoms, particularly when dose escalation follows the recommended gradual schedule
The solution should be clear and colorless
Educate patients on alternative options if they have difficulty mixing insulins, such as using premixed insulins, prefilled syringes, or taking separate injections
Common side effects include: Nausea Vomiting Diarrhea Decreased appetite Headache Stomach pain Fatigue Constipation Dizziness Heartburn Bloating and gas Low blood sugar (especially with insulin or sulfonylureas) Mood changes Serious, but rare side effects may include: Severe allergic reactions Pancreatitis Gallstones Kidney problems Worsening diabetic retinopathy Heart rate changes Suicidal thoughts or behaviors Thyroid cancer Bowel obstruction This is not a complete list
Because GIP receptor activation affects fat metabolism through pathways separate from appetite control, there is a theoretical basis for better weight maintenance at lower tirzepatide doses compared to equivalent semaglutide doses
